numbered

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Source Node:
Time Stamp: September 20, 2023 8:36 AM - Modified On: September 20, 2023 - Published By:
Source Cluster:
Republished By Plato

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers

VNX Gold token now available on LBank, expanding global interest in gold-backed digital assets

Source Node:
Time Stamp: November 2, 2022 12:50 PM - Modified On: November 2, 2022 - Published By:
Source Cluster:
Republished By Plato

[vc_row][vc_column][vc_column_text]Leading cryptocurrency exchange LBank, adds VNX Gold to its platform, becoming one of the exchanges to offer VNX’s asset-backed token tied to precious metals[/vc_column_text][vc_gallery type="flexslider_slide" interval="0" images="1733853,1733847,1733848,1733849,1733850,1733851,1733852" img_size="full" onclick=""][vc_column_text]Liechtenstein, November 2022 — VNX, Europe’s first regulated platform for investing in tokenized precious metals, announces that VNX Gold token is available on a top virtual asset exchange LBank. VNX Gold tokens represent an ownership stake of physical gold bullion certified by the London Bullion Market Association (LBMA). As the premier token of the VNX platform, VNX Gold empowers users to invest